Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
10.1210/er.2001-0033
Crossref journal-article
The Endocrine Society
Endocrine Reviews (80)
Bibliography

Firth, S. M., & Baxter, R. C. (2002). Cellular Actions of the Insulin-Like Growth Factor Binding Proteins. Endocrine Reviews, 23(6), 824–854.

Authors 2
  1. Sue M. Firth (first)
  2. Robert C. Baxter (additional)
References 394 Referenced 1,390
  1. 10.1016/S1569-2566(97)80036-1 / Adv Mol Cell Endocrinol / Molecular aspects of insulin-like growth factor binding proteins. by Baxter (1997)
  2. {'key': '2019041121411749800_R2', 'first-page': '29', 'article-title': 'Evolution of insulin-like growth factor binding proteins.', 'volume': '3', 'author': 'Upton', 'year': '1993', 'journal-title': 'Growth Regul'} / Growth Regul / Evolution of insulin-like growth factor binding proteins. by Upton (1993)
  3. {'key': '2019041121411749800_R3', 'first-page': '761', 'article-title': 'The insulin-like growth factor-binding protein (IGFBP) superfamily.', 'volume': '20', 'author': 'Hwa', 'year': '1999', 'journal-title': 'Endocr Rev'} / Endocr Rev / The insulin-like growth factor-binding protein (IGFBP) superfamily. by Hwa (1999)
  4. 10.1136/mp.54.5.317 / Mol Pathol / The Twisted gastrulation family of proteins, together with the IGFBP and CCN families, comprise the TIC superfamily of cysteine rich secreted factors. by Vilmos (2001)
  5. {'key': '2019041121411749800_R5', 'first-page': '69', 'article-title': 'Structural aspects of the IGFBP family.', 'volume': '2', 'author': 'Drop', 'year': '1992', 'journal-title': 'Growth Regul'} / Growth Regul / Structural aspects of the IGFBP family. by Drop (1992)
  6. {'key': '2019041121411749800_R6', 'first-page': 'E967', 'article-title': 'Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities', 'volume': '278', 'author': 'Baxter', 'year': '2000', 'journal-title': 'Am J Physiol'} / Am J Physiol / Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities by Baxter (2000)
  7. 10.1210/edrv.22.6.0449 / Endocr Rev / Use of mutagenesis to probe IGF-binding protein structure/function relationships. by Clemmons (2001)
  8. 10.1074/jbc.274.21.14587 / J Biol Chem / The N-terminal disulfide linkages of human insulin-like growth factor-binding protein-6 (hIGFBP-6) and hIGFBP-1 are different as determined by mass spectrometry. by Neumann (1999)
  9. 10.1677/joe.0.1680283 / J Endocrinol / Expression, purification and characterization of the structure and disulfide linkages of insulin-like growth factor binding protein-4. by Chelius (2001)
  10. 10.1093/emboj/17.22.6558 / EMBO J / Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions. by Kalus (1998)
  11. 10.1074/jbc.M000070200 / J Biol Chem / Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions. by Imai (2000)
  12. 10.1210/jcem.86.10.7936 / J Clin Endocrinol Metab / Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding. by Buckway (2001)
  13. 10.1074/jbc.M109604200 / J Biol Chem / Insulin-like growth factor binding protein-3 (IGFBP-3) mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. by Hong (2002)
  14. 10.1210/endo.137.8.8754741 / Endocrinology / A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. by Lalou (1996)
  15. 10.1054/ghir.2000.0180 / Growth Horm IGF Res / Characterization of an amino-terminal fragment of insulin-like growth factor binding protein-3 and its effects in MCF-7 breast cancer cells. by Salahifar (2000)
  16. 10.1074/jbc.273.8.4647 / J Biol Chem / Localization of an insulin-like growth factor (IGF) binding site of bovine IGF binding protein-2 using disulfide mapping and deletion mutation analysis of the C-terminal domain. by Forbes (1998)
  17. 10.1016/S0006-291X(88)80309-7 / Biochem Biophys Res Commun / Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factors. by Wang (1988)
  18. 10.1210/endo.138.9.5415 / Endocrinology / Characterization of truncated insulin-like growth factor-binding protein-2 in human milk. by Ho (1997)
  19. 10.1677/joe.0.1690123 / J Endocrinol / Ligand-binding characteristics of recombinant amino- and carboxyl-terminal fragments of human insulin-like growth factor-binding protein-3. by Galanis (2001)
  20. 10.1210/endo.141.11.7781 / Endocrinology / Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling. by Devi (2000)
  21. 10.1677/jme.0.0230117 / J Mol Endocrinol / Amino acids within the extracellular matrix (ECM) binding region (201–218) of rat insulin-like growth factor binding protein (IGFBP)-5 are important determinants in binding IGF-I. by Bramani (1999)
  22. 10.1073/pnas.90.22.10553 / Proc Natl Acad Sci USA / Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the α5β1 integrin by means of its Arg-Gly-Asp sequence. by Jones (1993)
  23. 10.1002/j.1460-2075.1989.tb08386.x / EMBO J / Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2). by Binkert (1989)
  24. 10.1074/jbc.273.5.2631 / J Biol Chem / Structural determinants of ligand and cell surface binding of insulin-like growth factor binding protein-3. by Firth (1998)
  25. 10.1074/jbc.273.44.28791 / J Biol Chem / Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit: role of the carboxyl-terminal domain. by Twigg (1998)
  26. 10.1210/endo.142.5.8284 / Endocrinology / Mutagenesis of basic amino acids in the carboxyl-terminal region of insulin-like growth factor binding protein-5 affects acid-labile subunit binding. by Firth (2001)
  27. 10.1210/endo.138.7.5230 / Endocrinology / Insulin-like growth factor binding protein-5 binds to plasminogen activator inhibitor-I. by Nam (1997)
  28. {'key': '2019041121411749800_R28', 'first-page': '1806', 'article-title': 'Transferrin is an insulin-like growth factor-binding protein-3 binding protein.', 'volume': '86', 'author': 'Weinzimer', 'year': '2001', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Transferrin is an insulin-like growth factor-binding protein-3 binding protein. by Weinzimer (2001)
  29. {'key': '2019041121411749800_R29', 'first-page': '1', 'article-title': 'IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain.', 'volume': '5', 'author': 'Booth', 'year': '1995', 'journal-title': 'Growth Regul'} / Growth Regul / IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain. by Booth (1995)
  30. 10.1074/jbc.M002208200 / J Biol Chem / Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin β subunit. by Schedlich (2000)
  31. 10.1677/joe.0.1600379 / J Endocrinol / Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3. by Firth (1999)
  32. 10.1210/endo-129-2-1006 / Endocrinology / Characterization of an insulin-like growth factor binding protein (IGFBP-4) produced by the B104 rat neuronal cell line: chemical and biological properties and differential synthesis by sublines. by Cheung (1991)
  33. 10.1016/S0303-7207(97)04032-X / Mol Cell Endocrinol / Phosphorylation of insulin-like growth factor binding proteins. by Coverley (1997)
  34. 10.1074/jbc.270.9.4395 / J Biol Chem / Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants. by Conover (1995)
  35. 10.1172/JCI119803 / J Clin Invest / Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture. by Imai (1997)
  36. 10.1210/endo.141.1.7375 / Endocrinology / A central domain binding site in insulin-like growth factor-binding protein 5 for the acid-labile subunit. by Twigg (2000)
  37. 10.1677/jme.0.0260229 / J Mol Endocrinol / The carboxy-terminal domain of IGF-binding protein-5 inhibits heparin binding to a site in the central domain. by Song (2001)
  38. 10.1210/endo.140.3.6566 / Endocrinology / Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule. by Yamanaka (1999)
  39. 10.1016/1043-2760(93)90085-S / Trends Endocrinol Metab / Circulating binding proteins for the insulinlike growth factors. by Baxter (1993)
  40. {'key': '2019041121411749800_R40', 'first-page': '3', 'article-title': 'Insulin-like growth factors and their binding proteins: biological actions.', 'volume': '16', 'author': 'Jones', 'year': '1995', 'journal-title': 'Endocr Rev'} / Endocr Rev / Insulin-like growth factors and their binding proteins: biological actions. by Jones (1995)
  41. 10.1016/0026-0495(95)90215-5 / Metabolism Clin Exp / Insulin-like growth factor binding proteins as glucoregulators by Baxter (1995)
  42. {'key': '2019041121411749800_R42', 'first-page': '801', 'volume': '18', 'author': 'Rajaram', 'journal-title': 'Endocr Rev'} / Endocr Rev by Rajaram
  43. 10.1677/jme.0.0210097 / J Mol Endocrinol / Insulin-like growth factor binding proteins: functional diversity or redundancy? by Murphy (1998)
  44. 10.1016/S0021-9258(18)80143-0 / J Biol Chem / High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum. by Baxter (1989)
  45. 10.1074/jbc.273.11.6074 / J Biol Chem / Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit. by Twigg (1998)
  46. 10.1210/jcem.87.1.8151 / J Clin Endocrinol Metab / Molecular distribution of IGF-binding protein-5 in human serum. by Baxter (2002)
  47. 10.1530/acta.0.1210753 / Acta Endocrinol (Copenh) / Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. by Guler (1989)
  48. 10.1210/endo.131.4.1382964 / Endocrinology / Determination of the pharmacokinetic profiles of insulin-like growth factor binding proteins-1 and -2 in rats. by Young (1992)
  49. 10.1210/endo.134.6.7514998 / Endocrinology / Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats. by Lewitt (1994)
  50. 10.1210/jcem-67-3-509 / J Clin Endocrinol Metab / Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. by Binoux (1988)
  51. 10.1210/endo.131.1.1377125 / Endocrinology / Insulin-like growth factor binding protein (IGFBP)4 accounts for the connective tissue distribution of endothelial cell IGFBPs perfused through the isolated heart. by Boes (1992)
  52. {'key': '2019041121411749800_R52', 'first-page': '32', 'article-title': 'Rapid clearance of human insulin-like growth factor binding protein-3 from the rat circulation and cellular localization in liver, kidney and stomach.', 'volume': '6', 'author': 'Arany', 'year': '1996', 'journal-title': 'Growth Regul'} / Growth Regul / Rapid clearance of human insulin-like growth factor binding protein-3 from the rat circulation and cellular localization in liver, kidney and stomach. by Arany (1996)
  53. 10.1210/endo.142.6.8192 / Endocrinology / Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism. by Miyakoshi (2001)
  54. 10.1677/joe.0.1360253 / J Endocrinol / Effect of human insulin-like growth factor-binding protein-1 on the half-life and action of administered insulin-like growth factor-I in rats. by Lewitt (1993)
  55. 10.1210/endo.143.5.8764 / Endocrinology / Impaired blockade of insulin-like growth factor (IGF)-I-induced hypoglycemia by IGF binding protein-3 analog with reduced ternary complex forming ability. by Firth (2002)
  56. 10.1074/jbc.272.26.16514 / J Biol Chem / Membrane-associated insulin-like growth factor-binding protein-3 inhibits insulin-like growth factor-I-induced insulin-like growth factor-I receptor signaling in Ishikawa endometrial cancer cells. by Karas (1997)
  57. 10.1210/endo.142.1.7915 / Endocrinology / Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity. by Ricort (2001)
  58. 10.1677/jme.0.0220141 / J Mol Endocrinol / Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells. by Perks (1999)
  59. 10.1074/jbc.272.18.12181 / J Biol Chem / Insulin like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. by Rajah (1997)
  60. 10.1006/bbrc.1998.8615 / Biochem Biophys Res Commun / Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells. by Firth (1998)
  61. 10.1210/endo.141.6.7520 / Endocrinology / Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway. by Miyake (2000)
  62. 10.1210/endo.141.9.7660 / Endocrinology / Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity. by Conover (2000)
  63. 10.1074/jbc.M006964200 / J Biol Chem / Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-β (TGF-β) and the type II TGF-β receptor. by Fanayan (2000)
  64. 10.1074/jbc.M002547200 / J Biol Chem / Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-α regulate transcriptional signaling and apoptosis. by Liu (2000)
  65. {'key': '2019041121411749800_R65', 'first-page': 'E744', 'article-title': 'Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor', 'volume': '274', 'author': 'Andress', 'year': '1998', 'journal-title': 'Am J Physiol'} / Am J Physiol / Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor by Andress (1998)
  66. 10.1046/j.1432-1327.2000.01575.x / Eur J Biochem / O-glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis. by Marinaro (2000)
  67. 10.1073/pnas.88.17.7481 / Proc Natl Acad Sci USA / Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. by Jones (1991)
  68. 10.1210/endo.141.2.7306 / Endocrinology / The effect of phosphorylation by casein kinase 2 on the activity of insulin-like growth factor binding protein. by Coverley (2000)
  69. {'key': '2019041121411749800_R69', 'first-page': '1752', 'article-title': 'The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-β.', 'volume': '79', 'author': 'Durham', 'year': '1994', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-β. by Durham (1994)
  70. {'key': '2019041121411749800_R70', 'first-page': 'F105', 'article-title': 'The IGF-I receptor in cell growth, transformation and apoptosis', 'volume': '1332', 'author': 'Baserga', 'year': '1997', 'journal-title': 'Biochim Biophys Acta'} / Biochim Biophys Acta / The IGF-I receptor in cell growth, transformation and apoptosis by Baserga (1997)
  71. 10.1074/jbc.270.49.29224 / J Biol Chem / In vivo coupling of insulin-like growth factor II/mannose 6-phosphate receptor to heteromeric G proteins. Distinct roles of cytoplasmic domains and signal sequestration by the receptor. by Ikezu (1995)
  72. 10.1146/annurev.bi.61.070192.001515 / Annu Rev Biochem / Structure and function of the mannose 6-phosphate/insulin-like growth factor II receptors. by Kornfeld (1992)
  73. 10.1002/(SICI)1097-4652(200001)182:1<62::AID-JCP7>3.0.CO;2-X / J Cell Physiol / Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells. by Scott (2000)
  74. 10.1111/j.1749-6632.1998.tb09634.x / Ann NY Acad Sci USA / The role of the insulin-like growth factor I receptor in transformation and apoptosis. by Resnicoff (1998)
  75. 10.1046/j.1440-1711.1999.00822.x / Immunol Cell Biol / The IGF axis and programmed cell death. by Butt (1999)
  76. 10.1016/0955-2235(95)00012-7 / Prog Growth Factor Res / Insulin-like growth factor binding protein (IGFBP) proteases: functional regulators of cell growth. by Rajah (1995)
  77. 10.1159/000184779 / Horm Res / Isolation and characterization of proteolytic fragments of insulin-like growth factor-binding protein-3. by Lalou (1996)
  78. 10.1016/S0021-9258(19)49788-3 / J Biol Chem / Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. by Camacho-Hubner (1992)
  79. 10.1210/endo.136.6.7538463 / Endocrinology / Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells. by Parker (1995)
  80. 10.1210/endo.138.4.5064 / Endocrinology / Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells—inhibition by IGFs does not require IGF-IGFBP interaction. by Salahifar (1997)
  81. 10.1161/01.RES.56.3.418 / Circ Res / Variables controlling the secretion of a somatomedin-like peptide by cultured porcine smooth muscle cells. by Clemmons (1985)
  82. 10.1677/joe.0.1250381 / J Endocrinol / Regulation of insulin-like growth factor-I gene expression by growth factors in cultured vascular smooth muscle cells. by Bornfeldt (1990)
  83. 10.1161/01.HYP.18.6.742 / Hypertension / Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells. by Delafontaine (1991)
  84. 10.1074/jbc.270.24.14383 / J Biol Chem / Regulation of vascular smooth muscle cell insulin-like growth factor I receptors by phosphorothioate oligonucleotides. Effects on cell growth and evidence that sense targeting at the ATG site increases receptor expression. by Delafontaine (1995)
  85. 10.1161/01.RES.76.6.963 / Circ Res / Inhibition of vascular smooth muscle cell growth through antisense transcription of a rat insulin-like growth factor I receptor cDNA. by Du (1995)
  86. 10.1074/jbc.273.27.16836 / J Biol Chem / Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells. by Duan (1998)
  87. 10.1016/S0303-7207(98)00024-0 / Mol Cell Endocrinol / Role of insulin-like growth factor binding proteins in controlling IGF actions. by Clemmons (1998)
  88. 10.1074/jbc.270.19.11377 / J Biol Chem / Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4. by Chernausek (1995)
  89. 10.1210/endo.139.10.6266 / Endocrinology / A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions. by Rees (1998)
  90. 10.1074/jbc.M112082200 / J Biol Chem / Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice results in IGFBP-4 stabilization and smooth muscle hypotrophy. by Zhang (2002)
  91. 10.1172/JCI116272 / J Clin Invest / Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. by Conover (1993)
  92. {'key': '2019041121411749800_R92', 'first-page': '104', 'article-title': 'Regulation of insulin-like growth factor (IGF)-binding protein-4 availability in normal human osteoblast-like cells: role of endogenous IGFs.', 'volume': '80', 'author': 'Durham', 'year': '1995', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Regulation of insulin-like growth factor (IGF)-binding protein-4 availability in normal human osteoblast-like cells: role of endogenous IGFs. by Durham (1995)
  93. 10.1002/jbmr.5650090115 / J Bone Miner Res / Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology. by Durham (1994)
  94. 10.1210/endo.134.1.7506211 / Endocrinology / Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases. by Kanzaki (1994)
  95. {'key': '2019041121411749800_R95', 'first-page': '619', 'article-title': 'Regulation of insulin-like growth factor-binding protein-4 in human endometrial stromal cell cultures: evidence for ligand-induced proteolysis.', 'volume': '80', 'author': 'Irwin', 'year': '1995', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Regulation of insulin-like growth factor-binding protein-4 in human endometrial stromal cell cultures: evidence for ligand-induced proteolysis. by Irwin (1995)
  96. 10.1210/endo.133.4.7691578 / Endocrinology / Insulin-like growth factor-I (IGF-I) enhanced proteolysis of IGF-binding protein-4 in conditioned medium from primary cultures of human decidua: independence from IGF receptor binding. by Myers (1993)
  97. 10.1093/molehr/4.4.401 / Mol Hum Reprod / Effect of follicle stimulating hormone and insulin-like growth factors on proteolysis of insulin-like growth factor binding protein-4 in human granulosa cells. by Iwashita (1998)
  98. 10.1073/pnas.96.6.3149 / Proc Natl Acad Sci USA / The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. by Lawrence (1999)
  99. 10.1006/abbi.2000.1872 / Arch Biochem Biophys / Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease. by Qin (2000)
  100. 10.1359/jbmr.1999.14.12.2079 / J Bone Miner Res / Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs. by Qin (1999)
  101. 10.1210/endo.142.5.8286 / Endocrinology / Pregnancy-associated plasma protein-A is the insulin-like growth factor binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of dominant follicle selection and the corpus luteum. by Conover (2001)
  102. 10.1210/endo.142.12.8517 / Endocrinology / Pregnancy-associated plasma protein-A (PAPP-A) in ovine, bovine, porcine, and equine ovarian follicles: involvement in IGF binding protein-4 proteolytic degradation and mRNA expression during follicular development. by Mazerbourg (2001)
  103. 10.1161/01.ATV.21.3.335 / Arterioscler Thromb Vasc Biol / Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. by Bayes-Genis (2001)
  104. 10.1016/S0014-5793(01)02760-0 / FEBS Lett / Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. by Laursen (2001)
  105. 10.1074/jbc.M102191200 / J Biol Chem / Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase. by Overgaard (2001)
  106. 10.1091/mbc.9.9.2383 / Mol Biol Cell / Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I. by Parker (1998)
  107. 10.1002/(SICI)1097-4644(19981201)71:3<375::AID-JCB6>3.0.CO;2-M / J Cell Biochem / Inhibition of IGFBP-5 binding to extracellular matrix and IGF-I-stimulated DNA synthesis by a peptide fragment of IGFBP-5. by Rees (1998)
  108. 10.1210/endo.141.3.7386 / Endocrinology / Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. by Nam (2000)
  109. 10.1083/jcb.121.3.679 / J Cell Biol / Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. by Jones (1993)
  110. 10.1074/jbc.M006107200 / J Biol Chem / The complement component C1 s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium. by Busby (2000)
  111. 10.1016/S0006-291X(05)80249-9 / Biochem Biophys Res Commun / Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. by Bautista (1991)
  112. 10.1172/JCI10459 / J Clin Invest / Evidence that IGF-binding protein-5 functions as a growth factor. by Miyakoshi (2001)
  113. 10.1359/jbmr.2000.15.5.902 / J Bone Miner Res / Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic-resorbing activity. by Kanatani (2000)
  114. 10.1016/S0021-9258(18)42332-0 / J Biol Chem / Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. by Kiefer (1992)
  115. {'key': '2019041121411749800_R115', 'first-page': '1153', 'article-title': 'Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells.', 'volume': '76', 'author': 'Conover', 'year': '1993', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells. by Conover (1993)
  116. 10.1016/S0021-9258(18)41695-X / J Biol Chem / Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. by Andress (1992)
  117. 10.1677/joe.0.1440539 / J Endocrinol / IGF binding proteins-4, -5 and -6 may play specialized roles during L6 myoblast proliferation and differentiation. by Ewton (1995)
  118. 10.1210/endo.136.2.7530651 / Endocrinology / Skeletal muscle cell-derived insulin-like growth factor (IGF) binding proteins inhibit IGF-I-induced myogenesis in rat L6E9 cells. by Silverman (1995)
  119. 10.1002/(SICI)1097-4652(199810)177:1<47::AID-JCP5>3.0.CO;2-E / J Cell Physiol / Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5. by Ewton (1998)
  120. 10.1083/jcb.133.3.683 / J Cell Biol / Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism. by James (1996)
  121. 10.1210/endo.136.11.7588242 / Endocrinology / Roles of insulin-like growth factor (IGF) receptors and IGF-binding proteins in IGF-II-induced proliferation and differentiation of L6A1 rat myoblasts. by Bach (1995)
  122. 10.1016/S0021-9258(19)39711-X / J Biol Chem / Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts. by Martin (1990)
  123. 10.1055/s-2007-978723 / Horm Metab Res / Insulin-like growth factor binding protein-6: the “forgotten” binding protein? by Bach (1999)
  124. 10.1677/joe.0.1490297 / J Endocrinol / Insulin-like growth factor-binding protein-6 produced by human PC-3 prostate cancer cells: isolation, characterization and its biological action. by Srinivasan (1996)
  125. 10.1074/jbc.270.21.12373 / J Biol Chem / A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-β and insulin-like growth factor binding protein-6, in a calcium- and cell density-dependent manner. by Kato (1995)
  126. 10.1016/S0303-7207(00)00444-5 / Mol Cell Endocrinol / Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced but not basal proliferation and adhesion of LIM 1215 colon cancer cells. by Leng (2001)
  127. 10.1046/j.1440-1746.2002.02703.x / J Gastroenterol Hepatol / Decreased production of insulin-like growth factor-binding protein (IGFBP)-6 by transfection of colon cancer cells with an antisense IGFBP-6 cDNA construct leads to stimulation of cell proliferation. by Kim (2002)
  128. 10.1002/jcp.10045 / J Cell Physiol / Inhibition of Caco-2 cell proliferation by all-trans retinoic acid: role of insulin-like growth factor binding protein-6. by Kim (2002)
  129. 10.1016/S0021-9258(18)54050-3 / J Biol Chem / Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101. by Jones (1993)
  130. 10.1006/abbi.1998.0797 / Arch Biochem Biophys / Phosphorylation of rat insulin-like growth factor binding protein-1 does not affect its biological properties. by Peterkofsky (1998)
  131. 10.1016/S0021-9258(18)68206-7 / J Biol Chem / Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid. Isolation of two forms with different biologic actions. by Busby Jr (1988)
  132. 10.1073/pnas.84.10.3254 / Proc Natl Acad Sci USA / An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. by Elgin (1987)
  133. 10.1016/S1096-6374(98)80323-7 / Growth Horm IGF Res / Phosphorylated insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) inhibits while non-phosphorylated IGFBP-1 stimulates IGF-I-induced amino acid uptake by cultured trophoblast cells. by Yu (1998)
  134. 10.1210/endo-122-5-2150 / Endocrinology / Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. by Ritvos (1988)
  135. 10.1074/jbc.M008359200 / J Biol Chem / Tissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1’s ability to inhibit insulin-like growth factor-I-stimulated protein synthesis. by Sakai (2001)
  136. {'key': '2019041121411749800_R136', 'first-page': '2060', 'article-title': 'Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGF-binding protein-1 suggests paracrine interactions at the decidua:trophoblast interface during human implantation.', 'volume': '86', 'author': 'Irwin', 'year': '2001', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGF-binding protein-1 suggests paracrine interactions at the decidua:trophoblast interface during human implantation. by Irwin (2001)
  137. 10.1016/S1096-6374(98)80318-3 / Growth Horm IGF Res / Insulin-like growth factor binding protein-1 binds to placental cytotrophoblast α5β1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures. by Irwin (1998)
  138. 10.1093/molehr/7.1.79 / Mol Hum Reprod / Regulation of IGF bioavailability in pregnancy. by Gibson (2001)
  139. 10.1210/endo.137.12.8940346 / Endocrinology / Combination of insulin-like growth factor (IGF)-I and IGF-binding protein-1 promotes fibroblast-embedded collagen gel contraction. by Lee (1996)
  140. 10.1111/1523-1747.ep12612755 / J Invest Dermatol / Co-administration of insulin-like growth factor (IGF)-I and IGF-binding protein-1 stimulates wound healing in animal models. by Tsuboi (1995)
  141. 10.3109/02844319409071187 / Scand J Plast Reconstr Surg Hand Surg / Insulin like growth factor-1 and -2 and their role in the re-epithelialisation of wounds; interactions with insulin like growth factor binding protein type 1. by Kratz (1994)
  142. {'key': '2019041121411749800_R142', 'first-page': '233', 'article-title': 'Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1.', 'volume': '115', 'author': 'Jyung', 'year': '1994', 'journal-title': 'Surgery'} / Surgery / Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1. by Jyung (1994)
  143. 10.1016/0014-4827(92)90089-Q / Exp Cell Res / Effect of recombinant IGF binding protein-1 on primary cultures of human keratinocytes and fibroblasts: selective enhancement of IGF-1 but not IGF-2-induced cell proliferation. by Kratz (1992)
  144. 10.1172/JCI119064 / J Clin Invest / Interaction between the insulin-like growth factor family and the integrin receptor family in tissue repair processes—evidence in a rabbit ear dermal ulcer model. by Galiano (1996)
  145. 10.1074/jbc.M101317200 / J Biol Chem / BIAcore analysis of bovine insulin-like growth factor (IGF)-binding protein-2 identifies major IGF binding site determinants in both the amino- and carboxyl-terminal domains. by Carrick (2001)
  146. 10.1016/S0014-5793(98)01011-4 / FEBS Lett / Insulin-like growth factor-binding protein-2 inhibits proliferation of human embryonic kidney fibroblasts and of IGF-responsive colon carcinoma cell lines. by Höflich (1998)
  147. 10.1006/bbrc.1995.1870 / Biochem Biophys Res Commun / Growth stimulation by transfection of intestinal epithelial cells with an antisense insulin-like growth factor binding protein-2 construct. by Corkins (1995)
  148. 10.1210/endo.142.5.8149 / Endocrinology / Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. by Höflich (2001)
  149. {'key': '2019041121411749800_R149', 'first-page': '4680', 'article-title': 'Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.', 'volume': '53', 'author': 'Reeve', 'year': '1993', 'journal-title': 'Cancer Res'} / Cancer Res / Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. by Reeve (1993)
  150. {'key': '2019041121411749800_R150', 'first-page': '82', 'article-title': 'IGFBP-2: an important regulator of insulin-like growth factor action in human lung tumours?', 'volume': '3', 'author': 'Reeve', 'year': '1993', 'journal-title': 'Growth Regul'} / Growth Regul / IGFBP-2: an important regulator of insulin-like growth factor action in human lung tumours? by Reeve (1993)
  151. 10.1210/endo-129-5-2631 / Endocrinology / Evaluation of the developmental and nutritional changes in porcine insulin-like growth factor-binding protein-1 and -2 serum levels by immunoassay. by McCusker (1991)
  152. 10.1016/0014-5793(89)81101-9 / FEBS Lett / Isolation from human cerebrospinal fluid of a new insulin-like growth factor-binding protein with a selective affinity for IGF-II. by Roghani (1989)
  153. 10.1002/jcp.1041640123 / J Cell Physiol / Regulation of insulin-like growth factor (IGF) binding protein-2 synthesis and degradation by platelet-derived growth factor and the IGFs is enhanced by serum deprivation in vascular smooth muscle cells. by Cohick (1995)
  154. 10.1161/01.RES.76.4.514 / Circ Res / Porcine aortic smooth muscle cells secrete a serine protease for insulin-like growth factor binding protein-2. by Gockerman (1995)
  155. 10.1210/endo.138.2.4919 / Endocrinology / Role of insulin-like growth factor binding protein-2 and its limited proteolysis in neuroblastoma cell proliferation-modulation by transforming growth factor-β and retinoic acid. by Menouny (1997)
  156. 10.1016/S0006-291X(88)80824-6 / Biochem Biophys Res Commun / Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. by De Mellow (1988)
  157. 10.1016/0531-5565(93)90063-J / Exp Gerontol / Insulin-like growth factor binding protein-3 is overexpressed in senescent and quiescent human fibroblasts. by Moerman (1993)
  158. {'key': '2019041121411749800_R158', 'first-page': 'E1057', 'article-title': 'Insulin-like growth factor binding protein-3 inhibits porcine granulosa cell function in vitro', 'volume': '268', 'author': 'Samaras', 'year': '1995', 'journal-title': 'Am J Physiol'} / Am J Physiol / Insulin-like growth factor binding protein-3 inhibits porcine granulosa cell function in vitro by Samaras (1995)
  159. 10.1210/endo-129-6-3259 / Endocrinology / Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3. by Conover (1991)
  160. 10.1210/endo.130.6.1375895 / Endocrinology / Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. by Conover (1992)
  161. 10.1210/endo.138.12.5714 / Endocrinology / Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: an alternative mechanism in the regulation of IGF action. by Mohseni-Zadeh (1997)
  162. 10.1002/jcp.1041580110 / J Cell Physiol / Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. by Chen (1994)
  163. 10.1210/endo-129-2-710 / Endocrinology / Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-I-induced receptor down-regulation and cell desensitization in cultured bovine fibroblasts. by Conover (1991)
  164. 10.1006/mgme.1999.2920 / Mol Genet Metab / Novel aspects of the insulin-like growth factor binding proteins. by Wetterau (1999)
  165. 10.1677/joe.0.1420407 / J Endocrinol / Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. by Cohen (1994)
  166. 10.1210/endo.136.12.7588299 / Endocrinology / Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). by Angelloz-Nicoud (1995)
  167. 10.1016/S1096-6374(98)80324-9 / Growth Horm IGF Res / Prostate carcinoma (PC-3) cell proliferation is stimulated by the 22–25-kDa proteolytic fragment (1–160) and inhibited by the 16-kDa fragment (1–95) of recombinant human insulin-like growth factor binding protein-3. by Angelloz-Nicoud (1998)
  168. 10.1677/jme.0.0230277 / J Mol Endocrinol / Complex mediation of uterine endometrial epithelial cell growth by insulin-like growth factor-II (IGF-II) and IGF-binding protein-2. by Badinga (1999)
  169. 10.1210/endo.136.10.7545101 / Endocrinology / Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells. by Slootweg (1995)
  170. {'key': '2019041121411749800_R170', 'first-page': '834', 'article-title': 'Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells.', 'volume': '60', 'author': 'Höflich', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells. by Höflich (2000)
  171. {'key': '2019041121411749800_R171'}
  172. 10.1046/j.1365-2265.2001.01221.x / Clin Endocrinol (Oxf) / Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly. by Miraki-Moud (2001)
  173. {'key': '2019041121411749800_R173', 'first-page': '411', 'article-title': 'Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate.', 'volume': '81', 'author': 'Tennant', 'year': '1996', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate. by Tennant (1996)
  174. 10.1016/S0021-9258(18)63879-7 / J Biol Chem / Inhibitory diffusible factor 45 bifunctional activity. As a cell growth inhibitor and as an insulin-like growth factor I-binding protein. by Blat (1989)
  175. 10.1002/jcp.1041490319 / J Cell Physiol / An IGF binding protein is an inhibitor of FGF stimulation. by Villaudy (1991)
  176. 10.1016/0014-4827(92)90428-B / Exp Cell Res / Stimulation by TGFβ of chick embryo fibroblasts-inhibition by an IGFBP-3. by Imbenotte (1992)
  177. {'key': '2019041121411749800_R177', 'first-page': '23', 'article-title': 'Transfection of the human IGFBP-3 gene into BALB/c fibroblasts—a model for the cellular functions of IGFBPs.', 'volume': '3', 'author': 'Cohen', 'year': '1993', 'journal-title': 'Growth Regul'} / Growth Regul / Transfection of the human IGFBP-3 gene into BALB/c fibroblasts—a model for the cellular functions of IGFBPs. by Cohen (1993)
  178. {'key': '2019041121411749800_R178', 'first-page': '361', 'article-title': 'The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene.', 'volume': '9', 'author': 'Valentinis', 'year': '1995', 'journal-title': 'Mol Endocrinol'} / Mol Endocrinol / The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. by Valentinis (1995)
  179. 10.1128/MCB.19.5.3278 / Mol Cell Biol / Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. by Frasca (1999)
  180. 10.1074/jbc.M005088200 / J Biol Chem / Antiproliferative effects of insulin-like growth factor-binding protein-3 in mesenchymal chondrogenic cell line RCJ3.1C5.18. Relationship to differentiation stage. by Spagnoli (2001)
  181. {'key': '2019041121411749800_R181', 'first-page': '1545', 'article-title': 'Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells.', 'volume': '56', 'author': 'Gucev', 'year': '1996', 'journal-title': 'Cancer Res'} / Cancer Res / Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells. by Gucev (1996)
  182. 10.1074/jbc.271.2.1016 / J Biol Chem / Estradiol and antiestrogens regulate a growth inhibitory insulin like growth factor binding protein 3 autocrine loop in human breast cancer cells. by Huynh (1996)
  183. 10.1677/jme.0.0200157 / J Mol Endocrinol / Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3. by Colston (1998)
  184. 10.1016/S0022-5347(01)69892-6 / J Urol / Insulin-like growth factor binding protein-3 mediates 1α,25-dihydroxyvitamin D3 growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. by Boyle (2001)
  185. {'key': '2019041121411749800_R185', 'first-page': '865', 'article-title': 'Antiproliferative action of tumor necrosis factor-α on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation.', 'volume': '13', 'author': 'Rozen', 'year': '1998', 'journal-title': 'Int J Oncol'} / Int J Oncol / Antiproliferative action of tumor necrosis factor-α on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. by Rozen (1998)
  186. 10.1038/377646a0 / Nature / Induction of the growth inhibitor IGF-binding protein 3 by p53. by Buckbinder (1995)
  187. {'key': '2019041121411749800_R187', 'first-page': '33', 'article-title': 'Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma.', 'volume': '5', 'author': 'Gray', 'year': '2000', 'journal-title': 'Int J Mol Med'} / Int J Mol Med / Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma. by Gray (2000)
  188. 10.1210/endo.142.9.8380 / Endocrinology / Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex. by Walker (2001)
  189. 10.1074/jbc.270.23.13589 / J Biol Chem / Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. by Oh (1995)
  190. {'key': '2019041121411749800_R190', 'first-page': 'L545', 'article-title': 'IGFBP-3 mediates TGF-β1-induced cell growth in human airway smooth muscle cells', 'volume': '278', 'author': 'Cohen', 'year': '2000', 'journal-title': 'Am J Physiol'} / Am J Physiol / IGFBP-3 mediates TGF-β1-induced cell growth in human airway smooth muscle cells by Cohen (2000)
  191. 10.1002/1097-0215(20000801)87:3<373::AID-IJC10>3.0.CO;2-X / Int J Cancer / IGFBP-3 mediates TGFβ1 proliferative response in colon cancer cells. by Kansra (2000)
  192. 10.1210/endo.138.7.5380 / Endocrinology / The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. by Zadeh (1997)
  193. 10.1016/S0006-291X(02)00181-X / Biochem Biophys Res Commun / The amino-terminal region of insulin-like growth factor binding protein-3, (1–95)IGFBP-3, induces apoptosis of MCF-7 breast carcinoma cells. by Bernard (2002)
  194. {'key': '2019041121411749800_R194', 'first-page': 'E450', 'article-title': 'Isolation and characterization of plasmin-generated bioactive fragments of IGFBP-3', 'volume': '39', 'author': 'Booth', 'year': '1999', 'journal-title': 'Am J Physiol'} / Am J Physiol / Isolation and characterization of plasmin-generated bioactive fragments of IGFBP-3 by Booth (1999)
  195. 10.1073/pnas.86.18.6898 / Proc Natl Acad Sci USA / Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. by Baxter (1989)
  196. {'key': '2019041121411749800_R196', 'first-page': '177', 'article-title': 'Insulin-like growth factor-binding protein-3 is functionally normal in pregnancy serum.', 'volume': '74', 'author': 'Suikkari', 'year': '1992', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Insulin-like growth factor-binding protein-3 is functionally normal in pregnancy serum. by Suikkari (1992)
  197. 10.1074/jbc.M002172200 / J Biol Chem / ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3. by Shi (2000)
  198. 10.1161/01.ATV.9.1.21 / Arteriosclerosis / Molecular modeling of protein-glycosaminoglycan interactions. by Cardin (1989)
  199. 10.1074/jbc.271.25.14676 / J Biol Chem / Characterization of glycosaminoglycan-binding domains present in insulin-like growth factor-binding protein-3. by Fowlkes (1996)
  200. 10.1210/endo.135.1.7516869 / Endocrinology / Insulin-like growth factor-binding protein-3 (IGFBP-3) concentration in rat Sertoli cell-conditioned medium is regulated by a pathway involving association of IGFBP-3 with cell surface proteoglycans. by Smith (1994)
  201. 10.1074/jbc.274.42.30215 / J Biol Chem / Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin. by Campbell (1999)
  202. {'key': '2019041121411749800_R202', 'first-page': 'E321', 'article-title': 'Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3', 'volume': '275', 'author': 'Campbell', 'year': '1998', 'journal-title': 'Am J Physiol'} / Am J Physiol / Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3 by Campbell (1998)
  203. {'key': '2019041121411749800_R203', 'first-page': '2104', 'article-title': 'Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/FN ternary complexes in human plasma.', 'volume': '86', 'author': 'Gui', 'year': '2001', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/FN ternary complexes in human plasma. by Gui (2001)
  204. 10.1016/S0014-5793(01)03204-5 / FEBS Lett / Transferrin binds insulin-like growth factors and affects binding properties of insulin-like growth factor binding protein-3. by Storch (2001)
  205. 10.1016/0009-8981(90)90278-Z / Clin Chim Acta / The biology of transferrin. by de Jong (1990)
  206. 10.1016/S0301-472X(00)00687-1 / Exp Hematol / Pro-apoptotic and anti-apoptotic effects of transferrin and transferrin-derived glycans on hematopoietic cells and lymphocytes. by Lesnikov (2001)
  207. 10.1023/A:1009515232450 / J Mammary Gland Biol Neoplasia / Insulin-like growth factor (IGF) system in the bovine mammary gland and milk. by Baumrucker (2000)
  208. 10.1006/bbrc.1993.2004 / Biochem Biophys Res Commun / Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. by Andress (1993)
  209. 10.1074/jbc.271.23.13523 / J Biol Chem / Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5. by Parker (1996)
  210. {'key': '2019041121411749800_R210', 'first-page': 'F899', 'article-title': 'Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration', 'volume': '273', 'author': 'Abrass', 'year': '1997', 'journal-title': 'Am J Physiol'} / Am J Physiol / Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration by Abrass (1997)
  211. 10.1074/jbc.271.11.6099 / J Biol Chem / Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I in response to heparin. by Arai (1996)
  212. 10.1016/S0021-9258(17)32004-5 / J Biol Chem / Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes. by Arai (1994)
  213. 10.1677/jme.0.0240043 / J Mol Endocrinol / Overlap of IGF- and heparin-binding sites in rat IGF-binding protein-5. by Song (2000)
  214. {'key': '2019041121411749800_R214', 'first-page': 'E1005', 'article-title': 'Insulin-like growth factor (IGF)-binding protein-5-(201–218) region regulates hydroxyapatite and IGF-I binding', 'volume': '273', 'author': 'Campbell', 'year': '1997', 'journal-title': 'Am J Physiol'} / Am J Physiol / Insulin-like growth factor (IGF)-binding protein-5-(201–218) region regulates hydroxyapatite and IGF-I binding by Campbell (1997)
  215. {'key': '2019041121411749800_R215', 'first-page': 'E1029', 'article-title': 'Effects and fate of human IGF-binding protein-5 in rat osteoblast cultures', 'volume': '271', 'author': 'Schmid', 'year': '1996', 'journal-title': 'Am J Physiol'} / Am J Physiol / Effects and fate of human IGF-binding protein-5 in rat osteoblast cultures by Schmid (1996)
  216. {'key': '2019041121411749800_R216', 'first-page': '59', 'article-title': 'Mice carrying null mutations of the genes encoding insulin-like growth factor I (igf-1) and type 1 IGF receptor (igf1r).', 'volume': '75', 'author': 'Liu', 'year': '1993', 'journal-title': 'Cell'} / Cell / Mice carrying null mutations of the genes encoding insulin-like growth factor I (igf-1) and type 1 IGF receptor (igf1r). by Liu (1993)
  217. 10.1210/endo.140.10.7081 / Endocrinology / Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. by Richman (1999)
  218. {'key': '2019041121411749800_R218', 'first-page': 'E283', 'article-title': 'IGF-binding protein-5 stimulates osteoblast activity and bone accretion in ovariectomized mice', 'volume': '28', 'author': 'Andress', 'year': '2001', 'journal-title': 'Am J Physiol'} / Am J Physiol / IGF-binding protein-5 stimulates osteoblast activity and bone accretion in ovariectomized mice by Andress (2001)
  219. {'key': '2019041121411749800_R219', 'first-page': '238', 'article-title': 'Growth hormone receptor activity is stimulated by insulin-like growth factor binding protein 5 in rat osteosarcoma cells.', 'volume': '6', 'author': 'Slootweg', 'year': '1996', 'journal-title': 'Growth Regul'} / Growth Regul / Growth hormone receptor activity is stimulated by insulin-like growth factor binding protein 5 in rat osteosarcoma cells. by Slootweg (1996)
  220. 10.1002/(SICI)1097-0215(19980911)77:6<874::AID-IJC13>3.0.CO;2-1 / Int J Cancer / IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity. by Menouny (1998)
  221. 10.1210/endo.139.8.6150 / Endocrinology / Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation. by Damon (1998)
  222. 10.1210/endo.142.5.8158 / Endocrinology / Inhibition of growth and increased expression of insulin-like growth factor-binding protein-3 (IGFBP-3) and -6 in prostate cancer cells stably transfected with antisense IGFBP-4 complementary deoxyribonucleic acid. by Drivdahl (2001)
  223. {'key': '2019041121411749800_R223', 'first-page': '237', 'article-title': 'The molecular effects of oncogenesis on cell-extracellular matrix adhesion.', 'volume': '19', 'author': 'Nadav', 'year': '2001', 'journal-title': 'Int J Oncol'} / Int J Oncol / The molecular effects of oncogenesis on cell-extracellular matrix adhesion. by Nadav (2001)
  224. 10.1006/scbi.2000.0362 / Semin Cancer Biol / Tumor invasion as dysregulated cell motility. by Kassis (2001)
  225. 10.1007/s004410050797 / Cell Tissue Res / Insulin-like growth factor-I stimulates in vitro migration of preosteoclasts across bone endothelial cells. by Formigli (1997)
  226. 10.1002/(SICI)1097-0215(19991112)83:4<497::AID-IJC11>3.0.CO;2-D / Int J Cancer / Integrins and E-cadherin cooperate with IGF-I to induce migration of epithelial colonic cells. by Andre (1999)
  227. {'key': '2019041121411749800_R227', 'first-page': '4369', 'article-title': 'Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility.', 'volume': '62', 'author': 'Zhang', 'year': '2002', 'journal-title': 'Cancer Res'} / Cancer Res / Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility. by Zhang (2002)
  228. 10.1038/ki.1997.193 / Kidney Int / Integrins as signaling molecules and targets for tumor therapy. by Ruoslahti (1997)
  229. 10.1210/endo.136.10.7545099 / Endocrinology / Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II. by Gockerman (1995)
  230. {'key': '2019041121411749800_R230', 'first-page': '2484', 'article-title': 'Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through α5β1 integrin via mitogen-activated protein kinase pathway.', 'volume': '86', 'author': 'Gleeson', 'year': '2001', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through α5β1 integrin via mitogen-activated protein kinase pathway. by Gleeson (2001)
  231. 10.1016/0020-7292(92)90772-B / Int J Gynaecol Obstet / Insulin-like growth factor binding protein-1 in female reproductive functions. by Rutanen (1992)
  232. {'key': '2019041121411749800_R232', 'author': 'Delhanty'} by Delhanty
  233. {'key': '2019041121411749800_R233'}
  234. 10.1016/S0014-5793(02)02935-6 / FEBS Lett / Mutation of the RGD sequence does not affect plasma membrane association and growth inhibitory effects of elevated IGFBP-2 in vivo. by Höflich (2002)
  235. 10.1073/pnas.93.6.2482 / Proc Natl Acad Sci USA / Ligand occupancy of the αV-β3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. by Jones (1996)
  236. 10.1046/j.1523-1755.2000.00049.x / Kidney Int / IGFBP-5(201–218) stimulates Cdc42GAP aggregation and filopodia formation in migrating mesangial cells. by Berfield (2000)
  237. 10.1210/mend-1-5-339 / Mol Endocrinol / Alterations in the synthesis of a fibroblast surface associated 35 K protein modulates the binding of somatomedin-C/insulin-like growth factor I. by Clemmons (1987)
  238. 10.1002/jcp.1041440210 / J Cell Physiol / Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs). by McCusker (1990)
  239. 10.1016/S0021-9258(19)38332-2 / J Biol Chem / Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity. by Clemmons (1990)
  240. 10.1172/JCI115441 / J Clin Invest / A unique receptor-independent mechanism by which insulinlike growth factor I regulates the availability of insulinlike growth factor binding proteins in normal and transformed human fibroblasts. by Conover (1991)
  241. 10.1210/endo.131.4.1382959 / Endocrinology / Insulin-like growth factor-I (IGF-I) and transforming growth factor-β1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. by Martin (1992)
  242. 10.1210/endo.138.11.5472 / Endocrinology / Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. by Russo (1997)
  243. 10.1210/endo.137.11.8895319 / Endocrinology / Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. by Arai (1996)
  244. 10.1210/endo.140.12.7169 / Endocrinology / Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. by Höflich (1999)
  245. 10.1210/endo.137.10.8828497 / Endocrinology / Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: role of heparan sulfate proteoglycans. by Yang (1996)
  246. 10.1042/bj2710773 / Biochem J / Glycosaminoglycans inhibit formation of the 140 kilodalton insulin-like growth factor-binding protein complex. by Baxter (1990)
  247. 10.1016/0955-2235(95)00004-6 / Prog Growth Factor Res / Modulation of human IGF binding protein-3 activity by structural modification. by Baxter (1995)
  248. 10.1210/mend-2-12-1176 / Mol Endocrinol / Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. by Wood (1988)
  249. 10.1016/S0014-5793(98)01497-5 / FEBS Lett / Isolation and characterization of circulating 13-kDa C-terminal fragments of human insulin-like growth factor binding protein-5. by Standker (1998)
  250. 10.1007/BF02108579 / Arch Gynecol / Isolation and characterization of a new placenta specific protein (PP12). by Bohn (1980)
  251. {'key': '2019041121411749800_R251', 'first-page': '46', 'article-title': 'Properties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3).', 'volume': '3', 'author': 'Sommer', 'year': '1993', 'journal-title': 'Growth Regul'} / Growth Regul / Properties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3). by Sommer (1993)
  252. 10.1006/prep.1999.1075 / Protein Expr Purif / Adenoviral-mediated expression of human insulin-like growth factor-binding protein-3. by Firth (1999)
  253. 10.1210/endo.136.12.7588336 / Endocrinology / Regulation of insulin-like growth factor (IGF) binding protein-3 phosphorylation by IGF-I. by Coverley (1995)
  254. 10.1016/S0021-9258(18)82426-7 / J Biol Chem / Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. by Oh (1993)
  255. 10.1677/joe.0.1680307 / J Endocrinol / Characterisation of insulin-like growth factor-binding protein-3 binding to a novel receptor on human platelet membranes. by Taylor (2001)
  256. 10.1016/S0021-9258(19)74273-2 / J Biol Chem / Demonstration of receptors for insulin-like growth factor binding protein-3 on HS578T human breast cancer cells. by Oh (1993)
  257. 10.1074/jbc.272.33.20572 / J Biol Chem / The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor. by Leal (1997)
  258. {'key': '2019041121411749800_R258', 'author': 'Ingermann', 'year': '2000'} by Ingermann (2000)
  259. 10.1074/jbc.270.47.28289 / J Biol Chem / Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells. by Andress (1995)
  260. 10.1074/jbc.M200885200 / J Biol Chem / Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and Erk1/2 pathways. by Kuemmerle (2002)
  261. 10.1016/S0021-9258(19)36793-6 / J Biol Chem / Transforming growth factor-β (TGF-β) type V receptor has a TGF-β-stimulated serine/threonine-specific autophosphorylation activity. by O’Grady (1992)
  262. {'key': '2019041121411749800_R262', 'first-page': 'F105', 'article-title': 'TGF-β receptor signaling', 'volume': '1333', 'author': 'Derynck', 'year': '1997', 'journal-title': 'Biochim Biophys Acta'} / Biochim Biophys Acta / TGF-β receptor signaling by Derynck (1997)
  263. 10.1074/jbc.272.30.18891 / J Biol Chem / Function of the type V transforming growth factor β receptor in transforming growth factor β-induced growth inhibition of mink lung epithelial cells. by Liu (1997)
  264. 10.1002/(SICI)1097-4644(20000501)77:2<288::AID-JCB11>3.0.CO;2-J / J Cell Biochem / Characterization of the inhibition of DNA synthesis in proliferating mink lung epithelial cells by insulin-like growth factor binding protein-3. by Wu (2000)
  265. 10.1074/jbc.274.10.6711 / J Biol Chem / Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-β receptor in mink lung epithelial cells. by Leal (1999)
  266. 10.1210/endo-128-3-1425 / Endocrinology / Transforming growth factor-β stimulates production of insulin-like growth factor binding protein-3 by human skin fibroblasts. by Martin (1991)
  267. 10.1074/jbc.M108038200 / J Biol Chem / Signaling through the Smad pathway by insulin-like growth factor binding protein-3 in breast cancer cells: relationship to transforming growth factor-β1 signaling. by Fanayan (2002)
  268. 10.1074/jbc.273.29.18347 / J Biol Chem / Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. by Schedlich (1998)
  269. 10.1210/endo.131.4.1382963 / Endocrinology / Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line. by Adamo (1992)
  270. 10.1002/jcp.1041600208 / J Cell Physiol / Regulation of insulin-like growth factor 1 binding protein 3 levels by epidermal growth factor and retinoic acid in cervical epithelial cells. by Andreatta-Van Leyen (1994)
  271. 10.1210/endo.136.3.7532580 / Endocrinology / Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol. by Martin (1995)
  272. 10.1016/S0303-7207(99)00122-7 / Mol Cell Endocrinol / Androgens decrease and retinoids increase the expression of insulin-like growth factor-binding protein-3 in LNCaP prostatic adenocarcinoma cells. by Goossens (1999)
  273. 10.1074/jbc.274.25.18005 / J Biol Chem / Signal relay by retinoic acid receptors α and β in the retinoic acid-induced expression of insulin-like growth factor-binding protein-3 in breast cancer cells. by Shang (1999)
  274. {'key': '2019041121411749800_R274', 'first-page': '1794', 'article-title': 'Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.', 'volume': '56', 'author': 'Hembree', 'year': '1996', 'journal-title': 'Cancer Res'} / Cancer Res / Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells. by Hembree (1996)
  275. 10.1016/0968-0004(94)90004-3 / Trends Biochem Sci / Nuclear localization signal in insulin-like growth factor-binding protein type 3. by Radulescu (1994)
  276. 10.1210/endo.138.4.5177 / Endocrinology / Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. by Jaques (1997)
  277. 10.1210/endo.138.4.5176 / Endocrinology / Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. by Li (1997)
  278. 10.1046/j.1523-1747.1998.00258.x / J Invest Dermatol / Intranuclear localization of insulin-like growth factor binding protein-3 (IGFBP-3) during cell division in human keratinocytes. by Wraight (1998)
  279. 10.1210/endo.143.7.8876 / Endocrinology / Insulin-like growth factor binding protein-3-induced growth inhibition and apoptosis do not require cell-surface binding and nuclear translocation in human breast cancer cells. by Butt (2002)
  280. 10.1016/S0959-440X(00)00165-2 / Curr Opin Struct Biol / Retinoid X receptor and its partners in the nuclear receptor family. by Rastinejad (2001)
  281. 10.1074/jbc.274.23.16407 / J Biol Chem / Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells. by Martin (1999)
  282. 10.1074/jbc.M200218200 / J Biol Chem / Identification of STAT-1 as a molecular target of insulin-like growth factor binding protein-3 (IGFBP-3) in the process of chondrogenesis. by Spagnoli (2002)
  283. 10.1101/gad.13.7.804 / Genes Dev / A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras. by Kretzschmar (1999)
  284. 10.1172/JCI6871 / J Clin Invest / Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3-dependent signal transduction by phosphorylating human retinoid X receptor α. by Solomon (1999)
  285. 10.1038/bjc.1996.523 / Br J Cancer / Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer. by Yu (1996)
  286. 10.1006/bbrc.1997.7089 / Biochem Biophys Res Commun / Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells. by Nickerson (1997)
  287. 10.1006/cbir.2001.0756 / Cell Biol Int / Effects of insulin-like growth factor-binding protein 2 and an IGF-type I receptor-blocking antibody on apoptosis in human teratocarcinoma cells in vitro. by Granerus (2001)
  288. 10.1074/jbc.274.11.6935 / J Biol Chem / The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells. by Manes (1999)
  289. 10.1016/S0167-4781(01)00204-4 / Biochim Biophys Acta / Checking out the G(2)/M transition. by Smits (2001)
  290. 10.1016/S0006-291X(02)00570-3 / Biochem Biophys Res Commun / Effects of a non-IGF binding mutant of IGFBP-5 on cell death in human breast cancer cells. by Perks (2002)
  291. 10.1016/S0006-291X(02)00569-7 / Biochem Biophys Res Commun / A non-IGF binding mutant of IGFBP-3 modulates cell function in breast epithelial cells. by Perks (2002)
  292. {'key': '2019041121411749800_R292', 'first-page': '137', 'article-title': 'Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089.', 'volume': '13', 'author': 'Huynh', 'year': '1998', 'journal-title': 'Int J Oncol'} / Int J Oncol / Regulation of insulin-like growth factor (IGF) II and IGF binding protein 3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25(OH)2D3 and its analog EB1089. by Huynh (1998)
  293. 10.1074/jbc.M005832200 / J Biol Chem / Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3′-kinase/Akt signaling pathway. by Chakravarthy (2000)
  294. 10.1002/(SICI)1097-4644(19991215)75:4<652::AID-JCB11>3.0.CO;2-0 / J Cell Biochem / Differential IGF-independent effects of insulin-like growth factor binding proteins (1–6) on apoptosis of breast epithelial cells. by Perks (1999)
  295. 10.1074/jbc.272.41.25602 / J Biol Chem / Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. by Gill (1997)
  296. 10.1210/endo.140.9.6984 / Endocrinology / The role of cell surface attachment and proteolysis in the insulin-like growth factor (IGF)-independent effects of IGF-binding protein-3 on apoptosis in breast epithelial cells. by Maile (1999)
  297. 10.1002/1097-0215(20001101)88:3<448::AID-IJC18>3.0.CO;2-V / Int J Cancer / Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cells. by Fowler (2000)
  298. {'key': '2019041121411749800_R298', 'first-page': '22', 'article-title': 'Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells.', 'volume': '60', 'author': 'Williams', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. by Williams (2000)
  299. 10.1074/jbc.M908888199 / J Biol Chem / Insulin-like growth factor-binding protein-3 modulates expression of bax and bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. by Butt (2000)
  300. 10.1002/1097-0215(20001101)88:3<336::AID-IJC3>3.0.CO;2-A / Int J Cancer / IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation. by Hollowood (2000)
  301. 10.1016/S0006-291X(02)00491-6 / Biochem Biophys Res Commun / Enhanced expression of insulin-like growth factor binding protein-3 sensitizes the growth inhibitory effect of anticancer drugs in gastric cancer cells. by Lee (2002)
  302. 10.1677/joe.0.1660553 / J Endocrinol / Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer. by Hochscheid (2000)
  303. 10.1002/pros.10068 / Prostate / Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo. by Devi (2002)
  304. 10.1124/mol.55.2.396 / Mol Pharmacol / Induction of p53-dependent, insulin-like growth factor-binding protein-3-mediated apoptosis in glioblastoma multiforme cells by a protein kinase Cα antisense oligonucleotide. by Shen (1999)
  305. 10.1016/S0006-2952(98)00045-8 / Biochem Pharmacol / Induction of apoptosis in glioblastoma cells by inhibition of protein kinase C and its association with the rapid accumulation of p53 and induction of the insulin-like growth factor-1-binding protein-3. by Shen (1998)
  306. 10.1016/S0092-8674(00)81871-1 / Cell / p53, The cellular gatekeeper for growth and division. by Levine (1997)
  307. {'key': '2019041121411749800_R307', 'first-page': '163', 'article-title': 'Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-α-induced apoptosis: role of Bcl-2 phosphorylation.', 'volume': '13', 'author': 'Rajah', 'year': '2002', 'journal-title': 'Cell Growth Differ'} / Cell Growth Differ / Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-α-induced apoptosis: role of Bcl-2 phosphorylation. by Rajah (2002)
  308. 10.1016/S0968-0004(00)01740-0 / Trends Biochem Sci / Life-or-death decisions by the Bcl-2 protein family. by Adams (2001)
  309. 10.1002/1097-4644(20010201)80:2<248::AID-JCB140>3.0.CO;2-4 / J Cell Biochem / Differential insulin-like growth factor (IGF)-independent interactions of IGF binding protein-3 and IGF binding protein-5 on apoptosis in human breast cancer cells. Involvement of the mitochondria. by Perks (2000)
  310. 10.1016/S0968-0004(01)01844-8 / Trends Biochem Sci / The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. by Adrain (2001)
  311. 10.1128/MCB.20.17.6483-6495.2000 / Mol Cell Biol / Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3. by Mannhardt (2000)
  312. 10.1074/jbc.M110872200 / J Biol Chem / Insulin-like growth factor binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). by Amaar (2002)
  313. 10.1023/A:1026321529451 / J Mammary Gland Biol Neoplasia / Interactions of prolactin and growth hormone (GH) in the regulation of mammary gland function and epithelial cell survival. by Flint (1997)
  314. 10.1210/endo.138.12.5619 / Endocrinology / Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat. by Tonner (1997)
  315. 10.1007/0-306-46832-8_5 / Adv Exp Med Biol / Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland. by Tonner (2000)
  316. 10.1016/S0090-4295(99)00421-5 / Urology / Bicalutamide (Casodex)-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins. by Nickerson (1999)
  317. {'key': '2019041121411749800_R317', 'first-page': '3392', 'article-title': 'Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins.', 'volume': '59', 'author': 'Nickerson', 'year': '1999', 'journal-title': 'Cancer Res'} / Cancer Res / Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins. by Nickerson (1999)
  318. 10.1677/joe.0.1600223 / J Endocrinol / Vitamin D analogue EB1089-induced prostate regression is associated with increased gene expression of insulin-like growth factor binding proteins. by Nickerson (1999)
  319. 10.1210/endo.139.2.5912 / Endocrinology / Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2, 3, 4, and 5. by Nickerson (1998)
  320. {'key': '2019041121411749800_R320', 'first-page': '3058', 'article-title': 'Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.', 'volume': '60', 'author': 'Miyake', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models. by Miyake (2000)
  321. 10.1002/(SICI)1097-4652(199610)169:1<23::AID-JCP3>3.0.CO;2-G / J Cell Physiol / Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation. by Stewart (1996)
  322. 10.1074/jbc.271.19.11330 / J Biol Chem / Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. by Stewart (1996)
  323. 10.1002/(SICI)1097-4652(200006)183:3<330::AID-JCP5>3.0.CO;2-N / J Cell Physiol / Tumor necrosis factor-α-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts. by Meadows (2000)
  324. 10.1530/jrf.0.1040225 / J Reprod Fertil / Changes in insulin-like growth factor-binding protein-2 and -3 in follicular fluid during atresia of follicles grown after ovulation in pigs. by Guthrie (1995)
  325. 10.1210/endo.139.12.6367 / Endocrinology / Expression of mouse ovarian insulin growth factor system components during follicular development and atresia. by Wandji (1998)
  326. 10.1095/biolreprod65.3.648 / Biol Reprod / Differentiation of dominant vs. subordinate follicles in cattle. by Fortune (2001)
  327. 10.1095/biolreprod63.2.390 / Biol Reprod / Insulin-like growth factor (IGF)-binding protein-4 proteolytic degradation in bovine, equine, and porcine preovulatory follicles: regulation by IGFs and heparin-binding domain-containing peptides. by Mazerbourg (2000)
  328. 10.1210/endo.138.9.5363 / Endocrinology / The mouse intraovarian insulin-like growth factor I system: departures from the rat paradigm. by Adashi (1997)
  329. 10.1210/endo.139.3.5845 / Endocrinology / Characterization and hormonal regulation of a rat ovarian insulin-like growth factor binding protein-5 endopeptidase: an FSH-inducible granulosa cell-derived metalloprotease. by Resnick (1998)
  330. {'key': '2019041121411749800_R330', 'first-page': '1723', 'article-title': 'Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle.', 'volume': '79', 'author': 'Zhou', 'year': '1994', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle. by Zhou (1994)
  331. 10.1016/S0167-4889(00)00136-1 / Biochim Biophys Acta / Distinct patterns of insulin-like growth factor binding protein (IGFBP)-2 and IGFBP-3 expression in oxidant exposed lung epithelial cells. by Besnard (2001)
  332. 10.1210/endo.137.1.8536625 / Endocrinology / Glucocorticoid-induced growth arrest of lung alveolar epithelial cells is associated with increased production of insulin-like growth factor binding protein-2. by Mouhieddine (1996)
  333. 10.1210/endo.135.1.7516870 / Endocrinology / Insulin-like growth factor-II (IGF-II), type 2 IGF receptor, and IGF-binding protein-2 gene expression in rat lung alveolar epithelial cells: relation to proliferation. by Mouhieddine (1994)
  334. 10.1016/S0021-9258(17)36761-3 / J Biol Chem / Insulin-like growth factors, their binding proteins, and transforming growth factor-β 1 in oxidant-arrested lung alveolar epithelial cells. by Cazals (1994)
  335. 10.1038/sj.onc.1203813 / Oncogene / Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells. by Sueoka (2000)
  336. 10.1006/bbrc.1999.1451 / Biochem Biophys Res Commun / Mitogenic and antiapoptotic effects of insulin-like growth factor binding protein-6 in the human osteoblastic osteosarcoma cell line Saos-2/B-10. by Schmid (1999)
  337. 10.1210/mend.14.9.0517 / Mol Endocrinol / Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene. by Wood (2000)
  338. {'key': '2019041121411749800_R338', 'author': 'Pintar'} by Pintar
  339. 10.1210/endo.135.4.7523094 / Endocrinology / Human insulin-like growth factor-binding protein-1 (hIGFBP-1) in transgenic mice: characterization and insights into the regulation of IGFBP-1 expression. by Dai (1994)
  340. 10.1210/endo.136.9.7544274 / Endocrinology / Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. by Rajkumar (1995)
  341. 10.1210/endo.138.7.5282 / Endocrinology / Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth. by Gay (1997)
  342. 10.2337/diabetes.49.3.457 / Diabetes / Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. by Crossey (2000)
  343. 10.1677/jme.0.0150293 / J Mol Endocrinol / Expression of human insulin-like growth factor-binding protein-3 in transgenic mice. by Murphy (1995)
  344. 10.1172/JCI118663 / J Clin Invest / Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. by Neuenschwander (1996)
  345. 10.1210/endo.142.5.8165 / Endocrinology / Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. by Modric (2001)
  346. 10.1210/endo.139.5.5986 / Endocrinology / Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle α-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia. by Wang (1998)
  347. 10.1172/JCI118982 / J Clin Invest / Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice. by Rajkumar (1996)
  348. 10.1530/acta.0.1190465 / Acta Endocrinol (Copenh) / Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma. by Yeoh (1988)
  349. 10.1523/JNEUROSCI.15-11-07344.1995 / J Neurosci / In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. by Ye (1995)
  350. 10.1016/S0006-8993(97)00676-8 / Brain Res / Impaired brain development and reduced astrocyte response to injury in transgenic mice expressing IGF binding protein-1. by Ni (1997)
  351. 10.1054/ghir.2000.0168 / Growth Horm IGF Res / Impaired brain development and hydrocephalus in a line of transgenic mice with liver-specific expression of human insulin-like growth factor binding protein-1. by Doublier (2000)
  352. 10.1016/S0022-3476(97)70014-3 / J Pediatr / Making a rational diagnosis of growth-hormone deficiency by Preece (1997)
  353. {'key': '2019041121411749800_R353', 'first-page': '3001', 'article-title': 'Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.', 'volume': '86', 'author': 'Marzullo', 'year': '2001', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. by Marzullo (2001)
  354. 10.1159/000185023 / Horm Res / The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia. by Baxter (1996)
  355. {'key': '2019041121411749800_R355', 'first-page': '89', 'article-title': 'Insulin-like growth factor binding protein-1 as a marker of the metabolic syndrome—a study in borderline hypertension.', 'volume': '7', 'author': 'Lemne', 'year': '1998', 'journal-title': 'Blood Press'} / Blood Press / Insulin-like growth factor binding protein-1 as a marker of the metabolic syndrome—a study in borderline hypertension. by Lemne (1998)
  356. 10.1016/S0140-6736(97)10384-1 / Lancet / Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. by Hankinson (1998)
  357. 10.1126/science.279.5350.563 / Science / Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. by Chan (1998)
  358. 10.1093/jnci/91.2.151 / J Natl Cancer Inst / Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. by Yu (1999)
  359. {'key': '2019041121411749800_R359', 'first-page': '345', 'article-title': 'A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.', 'volume': '9', 'author': 'Giovannucci', 'year': '2000', 'journal-title': 'Cancer Epidemiol Biomarkers Prev'} / Cancer Epidemiol Biomarkers Prev / A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. by Giovannucci (2000)
  360. 10.1093/jnci/92.19.1592 / J Natl Cancer Inst / Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. by Kaaks (2000)
  361. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1111>3.0.CO;2-# / Int J Cancer / Free insulin-like growth factor-I and breast cancer risk. by Li (2001)
  362. 10.1002/ijc.1265 / Int J Cancer / A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women. by Lukanova (2001)
  363. 10.1093/jnci/90.12.911 / J Natl Cancer Inst / Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. by Wolk (1998)
  364. 10.1002/ijc.2910620306 / Int J Cancer / Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. by Bruning (1995)
  365. 10.1530/eje.0.1400164 / Eur J Endocrinol / Serum IGF-binding protein-6 and prostate specific antigen in breast cancer. by Kaulsay (1999)
  366. 10.1159/000012052 / Oncology / Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women. by Vadgama (1999)
  367. 10.1046/j.1440-1622.1999.01610.x / Aust NZ J Surg / Serum levels of insulin-like growth factor binding protein-3 in benign and malignant breast disease. by Holdaway (1999)
  368. {'key': '2019041121411749800_R368', 'first-page': '1031', 'article-title': 'Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients.', 'volume': '76', 'author': 'Cohen', 'year': '1993', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. by Cohen (1993)
  369. {'key': '2019041121411749800_R369', 'first-page': '229', 'article-title': 'Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen.', 'volume': '77', 'author': 'Kanety', 'year': '1993', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. by Kanety (1993)
  370. 10.1046/j.1365-2265.1997.1100922.x / Clin Endocrinol (Oxf) / Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. by Ho (1997)
  371. {'key': '2019041121411749800_R371', 'first-page': '2308', 'article-title': 'Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor.', 'volume': '82', 'author': 'Flyvbjerg', 'year': '1997', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. by Flyvbjerg (1997)
  372. {'key': '2019041121411749800_R372', 'first-page': '103', 'article-title': 'Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.', 'volume': '3', 'author': 'Rocha', 'year': '1997', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. by Rocha (1997)
  373. {'key': '2019041121411749800_R373', 'first-page': '271', 'article-title': 'Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer.', 'volume': '78', 'author': 'Karasik', 'year': '1994', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer. by Karasik (1994)
  374. 10.1016/S1096-6374(98)80300-6 / Growth Horm IGF Res / Role of insulin-like growth factor-I (IGF-I) receptor, IGF-I, and IGF binding protein-2 in human colorectal cancers. by Mishra (1998)
  375. 10.1016/0014-5793(91)81298-M / FEBS Lett / Site-directed mutagenesis of the N-terminal region of IGF binding protein 1; analysis of IGF binding capability. by Brinkman (1991)
  376. 10.1074/jbc.273.31.19691 / J Biol Chem / Alanine screening mutagenesis establishes tyrosine 60 of bovine insulin-like growth factor binding protein-2 as a determinant of insulin-like growth factor binding. by Hobba (1998)
  377. 10.1210/jcem.83.4.4858 / J Clin Endocrinol Metab / Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine. by Vorwerk (1998)
  378. 10.1210/mend-5-7-987 / Mol Endocrinol / Mutations in the C-terminal part of insulin-like growth factor (IGF)-binding protein-1 result in dimer formation and loss of IGF binding capacity. by Brinkman (1991)
  379. {'key': '2019041121411749800_R379', 'first-page': 'E465', 'article-title': 'IGFBP-3 proteolysis by plasmin, thrombin, serum-heparin binding, IGF binding, and structure of fragments', 'volume': '271', 'author': 'Booth', 'year': '1996', 'journal-title': 'Am J Physiol'} / Am J Physiol / IGFBP-3 proteolysis by plasmin, thrombin, serum-heparin binding, IGF binding, and structure of fragments by Booth (1996)
  380. 10.1016/S0764-4469(97)85695-8 / C R Acad Sci III / Proteolytic fragments of insulin-like growth factor binding protein-3: N-terminal sequences and relationships between structure and biological activity. by Lalou (1997)
  381. {'key': '2019041121411749800_R381', 'first-page': '164', 'article-title': 'Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3.', 'volume': '1', 'author': 'Fielder', 'year': '1994', 'journal-title': 'Growth Regul'} / Growth Regul / Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3. by Fielder (1994)
  382. 10.1016/S0014-5793(99)00275-6 / FEBS Lett / The cleavage site specificity of human prostate specific antigen for insulin-like growth factor binding protein-3. by Okabe (1999)
  383. 10.1016/S0021-9258(18)47310-3 / J Biol Chem / Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. by Fowlkes (1994)
  384. 10.1016/S0014-5793(01)03267-7 / FEBS Lett / Decreased intracellular degradation of insulin-like growth factor binding protein-3 in cathepsin L-deficient fibroblasts. by Zwad (2002)
  385. 10.1210/endo.139.4.5945 / Endocrinology / Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin. by Zheng (1998)
  386. {'key': '2019041121411749800_R386', 'author': 'Xu'} by Xu
  387. {'key': '2019041121411749800_R387', 'author': 'Liu'} by Liu
  388. 10.1210/endo.143.1.8596 / Endocrinology / Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actions. by Nam (2002)
  389. 10.1093/nar/30.1.235 / Nucleic Acids Res / The PROSITE database, its status in 2002. by Falquet (2002)
  390. 10.1023/A:1006960004440 / Glycoconjugate J / NetOglyc: prediction of mucin-type O-glycosylation sites based on sequence context and surface accessibility. by Hansen (1998)
  391. 10.1016/S0021-9258(19)84446-0 / J Biol Chem / Insulin-like growth factor binding protein from human plasma. Purification and characterization. by Martin (1986)
  392. 10.1016/S0006-291X(05)80807-1 / Biochem Biophys Res Commun / Human insulin-like growth factor binding protein-6 is O-glycosylated. by Bach (1992)
  393. 10.1002/jcb.240560220 / J Cell Biochem / Identification of the major sites of phosphorylation in IGF binding protein-3. by Hoeck (1994)
  394. 10.1210/endo-128-6-2815 / Endocrinology / Differential effects of insulin-like growth factor (IGF)-I and IGF-II on the expression of IGF binding proteins (IGFBPs) in a rat neuroblastoma cell line: isolation and characterization of two forms of IGFBP-4. by Ceda (1991)
Dates
Type When
Created 22 years, 8 months ago (Dec. 4, 2002, 6:31 p.m.)
Deposited 4 years, 2 months ago (May 31, 2021, 8:38 p.m.)
Indexed 1 day, 8 hours ago (Aug. 27, 2025, 11:50 a.m.)
Issued 22 years, 8 months ago (Dec. 1, 2002)
Published 22 years, 8 months ago (Dec. 1, 2002)
Published Online 8 years, 9 months ago (Nov. 7, 2016)
Published Print 22 years, 8 months ago (Dec. 1, 2002)
Funders 0

None

@article{Firth_2002, title={Cellular Actions of the Insulin-Like Growth Factor Binding Proteins}, volume={23}, ISSN={1945-7189}, url={http://dx.doi.org/10.1210/er.2001-0033}, DOI={10.1210/er.2001-0033}, number={6}, journal={Endocrine Reviews}, publisher={The Endocrine Society}, author={Firth, Sue M. and Baxter, Robert C.}, year={2002}, month=dec, pages={824–854} }